血液静止构造膏施加抗肺癌作用:一项整合网络药理学,转录学和实验验证的研究

相关实验视频

Updated: May 4, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.8K

Qiaozhi Wang1, Juhe Wang2, Chuanhao Dai1

  • 1Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, People's Republic of China.

Cancer management and research
|December 24, 2025
PubMed
概括

这项研究确定了BSCO中的20种化学成分,并证明了其在体外和体内具有显著的抗肺癌作用. BSCO可能会准PI3K-Akt通路,为新型肺癌疗法提供潜力.

关键词:
这就是BSCOCO.这就是UPLC-Q-TOF-MS.血静止构成膏膏的组成肺癌是一种肺癌.药物-食品同类物质的同类物质.网络药理学 网络药理学转录组学分析的分析

更多相关视频

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.7K

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
689